intravitreal, VEGF Therapy, macula


CLASSIFIEDS

Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Cover Image Not Available

September 2012

Features

Immunomodulatory Therapy in Noninfectious Posterior Uveitis
By:  Omar Saleh, MD; Aleksandr Kagan, DO; Yoreh Barak, MD; Henry J. Kaplan, MD, FACS
Four therapies from which to choose.

The Treatment of Choroidal Melanoma: How, Why, When and by Whom?
By:  Bertil Damato, MD, PhD, FRCOphth
An ocular oncologist offers his clinical opinions.

Internal Limiting Membrane Peeling in Macular Hole Surgery
By:  Noemi Lois, MD, PhD, FRCS(ED); Kurt Spiteri-Cornish, MD, FRCOphth; Laura Ternent, PhD
What clinical and economic evidence exists to support ILM peeling?

Giant Retinal Tears After Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage
By:  Daniel L. Chao, MD, PhD; Marco Gonzalez, MD; Harry W. Flynn, JR., MD
A result of excessive vitreous base shaving?

RPS: From the Podium to the Practice
By:  Andrew E. Mathis, PhD, Medical Editor
Our coverage of the 2012 Retinal Physician Symposium continues.

Rebleeding After Diabetic Vitrectomy
By:  Jonathan M. Smith, MD; David H. W. Steel, MD
Recurrence of hemorrhage after vitrectomy can be a troublesome complication.

Departments

Upfront: From the Editor-in-Chief
By:  Peter K. Kaiser, M.D.
To peel or not to peel — That is the question

Subspecialty News
By:  Jerry Helzner, Senior Editor
FDA approves Lucentis for DME; Could an eyedrop treat wet AMD; LCA-causing gene is Isolated; Five-year follow-up on Lucentis for RVO; and more

Innovation in Retina
By:  Jerry Helzner, Senior Editor
Ocriplasmin: two decades of commitment to a concept.

Coding Q&A
New RAC verteporfin audits are being challenged




AWS-#2